IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

  • June 18, 2025
  • Home
  • USA
  • IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow